Vident Advisory, LLC Merck & Co., Inc. Transaction History
Vident Advisory, LLC
- $5.7 Trillion
- Q4 2024
A detailed history of Vident Advisory, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 154,837 shares of MRK stock, worth $14.2 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
154,837
Previous 224,182
30.93%
Holding current value
$14.2 Million
Previous $25.5 Billion
39.49%
% of portfolio
0.27%
Previous 0.64%
Shares
7 transactions
Others Institutions Holding MRK
# of Institutions
3,957Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.1 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.38 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.59 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $232B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...